Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

117.14
Delayed Data
As of Feb 24
 +0.25 / +0.21%
Today’s Change
79.23
Today|||52-Week Range
132.95
+3.96%
Year-to-Date
3 Most Wildly Overvalued Stocks in Healthcare
Feb 23 / MotleyFool.com - Paid Partner Content
These 3 Stocks Would Have Tripled Your Money Over the Last 3 Years
Feb 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close116.89
Today’s open116.00
Day’s range114.28 - 117.50
Volume207,216
Average volume (3 months)540,622
Market cap$5.1B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.56%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio109.5
Price/Sales12.92
Price/Book13.50

Competitors

 Today’s
change
Today’s
% change
MASIMasimo Corp+1.37+1.57%
WSTWest Pharmaceutical ...+0.36+0.43%
NUVANuVasive Inc+0.25+0.34%
DXCMDexCom Inc+0.54+0.69%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs